Hartford Financial Management’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.28K Sell
812
-1
-0.1% -$7 ﹤0.01% 280
2025
Q4
$4.46K Hold
813
﹤0.01% 299
2025
Q3
$3.24K Hold
813
﹤0.01% 310
2025
Q2
$2.2K Hold
813
﹤0.01% 321
2025
Q1
$4.25K Hold
813
﹤0.01% 309
2024
Q4
$6.24K Hold
813
﹤0.01% 313
2024
Q3
$7.61K Hold
813
﹤0.01% 314
2024
Q2
$8.71K Buy
+813
New +$11K ﹤0.01% 307

Other funds holding RLYB

Hartford Financial Management's RLYB Position: Q1 2026 in Review

Hartford Financial Management reduced its Rallybio (RLYB) stake by 0.12% in Q1 2026, selling an estimated $7 and leaving 812 shares worth $7.28K. The position accounts for ﹤0.01% of the portfolio, ranked #280.

Hartford Financial Management first reported a position in RLYB in Q2 2024 and has held it in 8 quarters since. The position peaked at $8.71K in Q2 2024. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • Hartford Financial Management held 812 shares of Rallybio worth $7.28K as of Q1 2026.
  • Hartford Financial Management sold 1 Rallybio share in Q1 2026, an estimated $7.
  • Rallybio made up ﹤0.01% of Hartford Financial Management's portfolio in Q1 2026, its #280 holding.
  • Hartford Financial Management first reported a position in Rallybio in Q2 2024 and has held it in 8 quarters since.
  • Hartford Financial Management's Rallybio position peaked at $8.71K in Q2 2024.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on Hartford Financial Management's 13F filing for Q1 2026, filed 16 Apr 2026.